Last reviewed · How we verify
Diuretic Suspension (DS)
Diuretic Suspension promotes fluid and electrolyte excretion through the kidneys to reduce fluid overload and blood pressure.
Diuretic Suspension promotes fluid and electrolyte excretion through the kidneys to reduce fluid overload and blood pressure. Used for Edema associated with congestive heart failure, Hypertension, Fluid overload.
At a glance
| Generic name | Diuretic Suspension (DS) |
|---|---|
| Sponsor | Medtronic BRC |
| Drug class | Diuretic |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
Diuretics work by inhibiting reabsorption of sodium and chloride in the renal tubules, which increases urine output and reduces circulating fluid volume. This mechanism decreases preload on the heart and lowers blood pressure, making diuretics useful for managing edema, hypertension, and heart failure. The specific class and molecular target of this suspension formulation are not clearly specified in available data.
Approved indications
- Edema associated with congestive heart failure
- Hypertension
- Fluid overload
Common side effects
- Hypokalemia
- Hyperuricemia
- Ototoxicity
- Electrolyte imbalances
- Dehydration
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diuretic Suspension (DS) CI brief — competitive landscape report
- Diuretic Suspension (DS) updates RSS · CI watch RSS
- Medtronic BRC portfolio CI